2021 May 27 - Knowledge Resource Webinar Series - Applications for Splice Variants, Short Targets, & Point Mutations
Anushka Dikshit, Ph.D.
Applications Scientist, Genomics, Advanced Cell Diagnostics
Watch Video:
Outline:

The BaseScope assay is a specialized RNA in situ hybridization (ISH) method which has a unique signal amplification system that allows for highly sensitive and specific detection of single nucleotide point mutations, distinguish between splice variants of a target gene and detect short sequences. Alternative tools such as PCR, sequencing and Northern blot are sensitive and specific but are unable to provide spatial information about target transcript expression. The BaseScope assay has been successfully used to assess target expression in Oncology, Neuroscience, Infectious disease and Developmental Biology research areas.

 

 
Learning Objectives:
  • Introduction to the BaseScope technology and workflow
  • Visualizing specific CDR3 sequences on T cells in tumor samples
  • Simultaneous detection of two variants of the same gene
  • Detecting circular RNA and other splice variants implicated in neurological diseases
  • Detecting point mutations in sub-clonal populations within heterogenous tumors
X
Contact Us

Complete one of the three forms below and we will get back to you.

For Quote Requests, please provide more details in the Contact Sales form below

Advanced Cell Diagnostics

Our new headquarters office starting May 2016:

7707 Gateway Blvd.  
Newark, CA 94560
Toll Free: 1 (877) 576-3636
Phone: (510) 576-8800
Fax: (510) 576-8798

 

Bio-Techne

19 Barton Lane  
Abingdon Science Park
Abingdon
OX14 3NB
United Kingdom
Phone 2: +44 1235 529449
Fax: +44 1235 533420

 

Advanced Cell Diagnostics China

20F, Tower 3,
Raffles City Changning Office,
1193 Changning Road, Shanghai 200051

021-52293200
info.cn@bio-techne.com
Web: www.acdbio.com/cn

For general information: Info.ACD@bio-techne.com
For place an order: order.ACD@bio-techne.com
For product support: support.ACD@bio-techne.com
For career opportunities: hr.ACD@bio-techne.com